Innate Pharma (IPHA) Q3 2025 Earnings

17SepConfirmed
Q1 2024
Q3 2024
Q1 2025
Q3 2025
-0.33
-0.22
-0.11
0

Details

Expected EPS
-0.3298372
Actual EPS
-0.2944975
Surprise EPS
0.04
Surprise Percent
+10.71%

Description

Innate Pharma (IPHA) has reported earnings of -0.2944975 per share for Q3 2025.

0 Comments

Share your thoughts